Effect of enzyte on QT and QTC intervals

Archives of Internal Medicine

Volumn 170, Issue 15, 2010, Pages 1402-1404

  Phillips, Mark ^a   Sullivan, Bridgette ^a   Snyder, Brenda ^a   Allegretti, Paul J ^a   McBride, Brian F ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; ENZYTE; PLACEBO; UNCLASSIFIED DRUG;

ABSORPTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELECTROCARDIOGRAM; HAZARD RATIO; HUMAN; HUMAN EXPERIMENT; LETTER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR;

ADULT; CROSS-OVER STUDIES; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; HEART CONDUCTION SYSTEM; HUMANS; MALE; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77955440883     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.254     Document Type: Letter

References (6)

1. Morrow JD. Why the United States still needs improved dietary supplement regulation and oversight. Clin Pharmacol Ther. 2008;83(3):391-393.
2. Morrow JD, Edeki TI, El Mouelhi M, et al; American Society for Clinical Pharmacology and Therapeutics. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther. 2005;77(3):113-122.
3. Food and Drug Administration, HHS. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability: notice. Fed Regist. 2005;70(202):61134-61135.
4. Wang SH, Lin CY, Huang TY, Wu ES, Chen CC, Tsai S. QT interval effects of cisapride in the clinical setting. Int J Cardiol. 2001;80(2-3):179-183. (Pubitemid 32905408)
5. Gillen MS, Miller B, Chaikin P, Morganroth J. Effect of supratherapeutic doses of ebastine and terfenadine on the QTc interval. Br J Clin Pharmacol. 2001;52(2):201-204. (Pubitemid 32863080)
6. Li EC, Estery JS, Pohl S, Scott SD, McBride BF. Drug-induced QT prolongation. Pharmacotherapy. In press.